BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8143137)

  • 1. Calmodulin-activated bacterial adenylate cyclases as virulence factors.
    Mock M; Ullmann A
    Trends Microbiol; 1993 Aug; 1(5):187-92. PubMed ID: 8143137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between the calmodulin-dependent adenylate cyclases produced by Bacillus anthracis and Bordetella pertussis.
    Robertson DL
    Biochem Biophys Res Commun; 1988 Dec; 157(3):1027-32. PubMed ID: 2905126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural homology between virulence-associated bacterial adenylate cyclases.
    Escuyer V; Duflot E; Sezer O; Danchin A; Mock M
    Gene; 1988 Nov; 71(2):293-8. PubMed ID: 2906312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A particular class of virulence factors: calmodulin-activated bacterial adenylate cyclases.
    Ullmann A; Mock M
    Zentralbl Bakteriol; 1994 Oct; 281(3):284-95. PubMed ID: 7696748
    [No Abstract]   [Full Text] [Related]  

  • 5. Bordetella pertussis adenylate cyclase: a toxin with multiple talents.
    Goyard S; Sebo P; D'Andria O; Ladant D; Ullmann A
    Zentralbl Bakteriol; 1993 Apr; 278(2-3):326-33. PubMed ID: 8347936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of bacterial pathogenicity that involve production of calmodulin-sensitive adenylate cyclases.
    Masure HR; Shattuck RL; Storm DR
    Microbiol Rev; 1987 Mar; 51(1):60-5. PubMed ID: 2882409
    [No Abstract]   [Full Text] [Related]  

  • 7. Functional consequences of single amino acid substitutions in calmodulin-activated adenylate cyclase of Bordetella pertussis.
    Glaser P; Munier H; Gilles AM; Krin E; Porumb T; Bârzu O; Sarfati R; Pellecuer C; Danchin A
    EMBO J; 1991 Jul; 10(7):1683-8. PubMed ID: 2050107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of mutant Bordetella pertussis adenylate cyclase toxins with reduced affinity for calmodulin. Implications for the mechanism of toxin entry into target cells.
    Heveker N; Ladant D
    Eur J Biochem; 1997 Feb; 243(3):643-9. PubMed ID: 9057827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adenylate cyclase toxins.
    Ahuja N; Kumar P; Bhatnagar R
    Crit Rev Microbiol; 2004; 30(3):187-96. PubMed ID: 15490970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The adenylate cyclase toxins of Bacillus anthracis and Bordetella pertussis promote Th2 cell development by shaping T cell antigen receptor signaling.
    Rossi Paccani S; Benagiano M; Capitani N; Zornetta I; Ladant D; Montecucco C; D'Elios MM; Baldari CT
    PLoS Pathog; 2009 Mar; 5(3):e1000325. PubMed ID: 19266022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenylate cyclases involvement in pathogenicity, a minireview.
    Costache A; Bucurenci N; Onu A
    Roum Arch Microbiol Immunol; 2013; 72(1):63-86. PubMed ID: 23947014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a common domain in calmodulin-activated eukaryotic and bacterial adenylate cyclases.
    Goyard S; Orlando C; Sabatier JM; Labruyere E; d'Alayer J; Fontan G; van Rietschoten J; Mock M; Danchin A; Ullmann A
    Biochemistry; 1989 Mar; 28(5):1964-7. PubMed ID: 2470405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-protein docking and analysis reveal that two homologous bacterial adenylyl cyclase toxins interact with calmodulin differently.
    Guo Q; Jureller JE; Warren JT; Solomaha E; Florián J; Tang WJ
    J Biol Chem; 2008 Aug; 283(35):23836-45. PubMed ID: 18583346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compartmentalized Cyclic AMP Production by the
    Arumugham VB; Ulivieri C; Onnis A; Finetti F; Tonello F; Ladant D; Baldari CT
    Front Immunol; 2018; 9():919. PubMed ID: 29765373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Bordetella pertussis and Bacillus anthracis adenylyl cyclases by polyadenylate and "P"-site agonists.
    Johnson RA; Shoshani I
    J Biol Chem; 1990 Nov; 265(31):19035-9. PubMed ID: 2121733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive adenylate cyclase toxin of Bordetella pertussis.
    Hanski E
    Trends Biochem Sci; 1989 Nov; 14(11):459-63. PubMed ID: 2560273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of 3'-anthraniloyl-2'-deoxy-ATP to calmodulin-activated adenylate cyclase from Bordetella pertussis and Bacillus anthracis.
    Sarfati RS; Kansal VK; Munier H; Glaser P; Gilles AM; Labruyère E; Mock M; Danchin A; Bârzu O
    J Biol Chem; 1990 Nov; 265(31):18902-6. PubMed ID: 2172237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An extended conformation of calmodulin induces interactions between the structural domains of adenylyl cyclase from Bacillus anthracis to promote catalysis.
    Drum CL; Yan SZ; Sarac R; Mabuchi Y; Beckingham K; Bohm A; Grabarek Z; Tang WJ
    J Biol Chem; 2000 Nov; 275(46):36334-40. PubMed ID: 10926933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-directed mutagenesis of lysine 58 in a putative ATP-binding domain of the calmodulin-sensitive adenylate cyclase from Bordetella pertussis abolishes catalytic activity.
    Au DC; Masure HR; Storm DR
    Biochemistry; 1989 Apr; 28(7):2772-6. PubMed ID: 2545236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis.
    Weiss AA; Hewlett EL; Myers GA; Falkow S
    J Infect Dis; 1984 Aug; 150(2):219-22. PubMed ID: 6088647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.